TRANSIRA THERAPEUTICS LLC
Getzville, NY · Biotech · Private
Oral peptide dual agonist (GIPR/GLP-1R) using proprietary peptide stapling chemistry for diabetes and obesity treatment
- Grants
- $1.0M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of stapled oxyntomodulin-Fc fusion proteins for the treatment of diabetes and obesity | $224,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of stapled oxyntomodulin-Fc fusion proteins for the treatment of diabetes and obesity | $224,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of Orally Administered Peptide Hormones for Treatment of Diabetes and Obesity | $300,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of Orally Administered Peptide Hormones for Treatment of Diabetes and Obesity | $300,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3035 | Twenty First Century Therapeutics, Inc. | — | — |
| 3036 | Surface Oncology | — | — |
| 3037 | OPSIN BIOTHERAPEUTICS INC. | — | — |
| 3038 | TRANSIRA THERAPEUTICS LLC | — | — |
| 3039 | ECMedical LLC | — | — |
| 3040 | GENETOBE INC | — | — |
| 3041 | DISCOVERY GENOMICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Stapled Peptides, Methods Of Making Same, And Uses Thereofapplication
- Stapled Peptides, Methods Of Making Same, And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.